# Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41419-026-09367-9) · 2026-11-17 · Life
Page: https://themorning.science/story/deubiquitination-of-c-ebp-by-fam63a-mediates-resistance-to-glutaminolysis-inhibi-ab6c6c498973888f
Kind: research · Impact: low

## In brief

- A study reports that FAM63A deubiquitinates C/EBPβ in MYC-amplified hepatocellular carcinoma.
- The deubiquitination is described as mediating resistance to glutaminolysis inhibition.
- The article was listed in a nature.com subject feed dated 2026-11-17 with no summary provided.

## Why it matters

The work points to a possible mechanism by which MYC-amplified liver cancer cells evade therapies targeting glutamine metabolism, which may inform future drug combination research.

## Timeline

- 2026-11-17: Article listed in nature.com subject feed

## Coverage

- [Deubiquitination of C/EBPβ by FAM63A mediates resistance to glutaminolysis inhibition in MYC-amplified hepatocellular carcinoma](https://www.nature.com/articles/s41419-026-09367-9) — Biological sciences : nature.com subject feeds, 2026-11-17

Tags: liver cancer, glutaminolysis, deubiquitination, c/ebpβ, myc

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
